📌 Key Takeaways
- Topic: Monodisperse Silica Spheres: Size Control, Synthesis and Applications
- Keywords: how to modify nano silica
- Published: 2026-11-20 13:27:50
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Pharmaceutical Grade Silica: Specifications, USP/EP Standards and Uses as an Excipient
- Is Silica in Cosmetics Safe? Ingredient Safety and Regulatory Status
- Is Silica in Toothpaste Safe? Abrasiveness, Enamel Effects and Safety
- Silica Filler for CCL: How It Improves Copper Clad Laminate Performance
- High Purity Quartz Supplier: Global Sources, Purity Grades and Selection Tips
- In this process, nanozymes are capable of following enzyme kinetics under physiological conditions and catalyzing the conversion of enzyme substrates by mimicking the structure or function of natural enzymes. Current nanozymes are dominated by oxidoreductase activity, i.e., oxidative stress amplification-related POD or OXD mimics, 423, 424 and antioxidation-related CAT or SOD mimics. 425, 426 By designing nanozymes with various catalytic activities, the redox balance of cells can be precisely regulated, i.e., enhanced ROS generation or ROS scavenging, enabling symptomatic treatment in a variety of disease models. 427, 428, 429, 430 Owing to the rich and tunable pore structure, MSNs have become a brilliant nanoreactor in enzyme-like catalytic therapy. 431, 432, 433, 434, 435 In a study by Wu et al., MSNs were developed as a compartmental hierarchical nanoreactor for multi-pathway generation of 1 O 2. Specifically, they designed a compartmental multienzyme nanoreactor with penetrated super cavity and connected dual mesoporous channels for the encapsulation of a multi-enzyme complex (SOD-lactoperoxidase (LPO)) and a photosensitizer ICG molecule. The cascade biocatalysis and enzyme-enhanced photosensitization could occur in parallel, due to the unimpeded substrate diffusion between SOD and LPO and reduced external diffusion effects. This strategy offers unique perks in the treatment of hypoxia tumors. 436 In terms of MSNs-based ROS elimination platform, Purikova et al. filled ultrasmall cerium dioxide (CeO 2 ) NPs with superior colloidal stability into the pore channels of MSNs, and functionalized the MSNs surface with ROS-responsive methylthiopropyl groups. The released CeO 2 NPs could scavenge more than 80% of H 2 O 2 within 10 min in an ROS-excess environment, which was demonstrated to be a potentially secure and productive antioxidant therapeutic agent. 437
What Is Silica Aerogel? Structure, Thermal Performance and Insulation Applications
What is silica (SiO₂)?
silicon dioxide in food
What is the difference between fumed silica and precipitated silica?
quartz for engineered stone With the rapid expansion of nanotechnology, nanomaterials have demonstrated great promise in the biomedical field due to their outstanding physicochemical properties. A variety of nanoformulations have been widely explored and developed for cargo delivery, 1, 2, 3, 4, 5 sickness diagnosis, 6, 7, 8, 9 and therapeutic purposes. 10, 11, 12, 13 Compared to macroscale counterparts, nanoformulations always enjoy the distinctive merits, including higher bioavailability, cut down toxic effects and boosted selectivity, in the living organism. 14 Typically, nanoformulations contain two major categories: organic and inorganic nanoformulations. 14, 15 Organic ones such as liposomes and polymers have been demonstrated to be a really effective and secure class of drug carriers, as evidenced by the fact that Doxil l is the first American Food and Drug Administration (FDA)-approved nanoliposomal drug formulation, 16 and the recently reported development of two lipid nanoparticles (NPs)-based COVID-19 mRNA vaccines (BNT162b2 and mRNA-1273). 17 For inorganic NPs-based formulations, though they are slightly inferior to organic NPs-based formulations in terms of biocompatibility and safety, they are superior to organic NPs-based formulations in terms of stability and drug delivery efficiency. Importantly, some distinctive properties possessed by inorganic NPs such as optical, ultrasonic, magnetic and catalytic properties have given rise to some novel NPs-based therapies, i.e., photothermal therapy (PTT), 18, 19 photodynamic therapy (PDT), 20, 21 sonodynamic therapy (SDT), 22, 23 chemodynamic therapy (CDT) 24, 25 and nanozyme-based catalytic therapy. 26, 27 Encouragingly, inorganic NPs are also steadily moving to the clinical stage, with about 25 inorganic nanomedicines approved for clinical use. 28
What drives silica raw material prices?
polysilicon de Lázaro, I. & Mooney, D. J. Obstacles and chances in a forward vision for cancer nanomedicine. Nat. Mater. 20, 1469-1479 (2021). Article PubMed Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.